Principal Financial Group Inc Xeris Biopharma Holdings, Inc. Transaction History
Principal Financial Group Inc
- $167 Billion
- Q1 2025
A detailed history of Principal Financial Group Inc transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 113,746 shares of XERS stock, worth $525,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,746
Previous 113,217
0.47%
Holding current value
$525,506
Previous $383,000
62.92%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
204Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$47.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$37.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$19.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$15.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$15.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $628M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...